Brief: Voyager Therapeutics Q1 Collaboration Revenue USD 2.593 Million
07/05/2026 21:01
May 07 (Reuters) - Voyager Therapeutics Q1 net income USD -27.937 million. Q1 basic EPS USD -0.47 Q1 operating income USD -30.27 million Q1 pretax profit USD -27.923 million
Recent news on Voyager Therapeutics
See all newsBrief: Voyager Names Robin Swartz As President; Expected To Succeed As CEO In Q1 2027
Voyager Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Voyager Therapeutics Q2 collaboration revenue falls, net loss narrows
Brief: Voyager Therapeutics Q2 Net Income USD -24.473 Million
Voyager Therapeutics Inc expected to post a loss of 48 cents a share - Earnings Preview